Federal Funding in Otolaryngology–Head and Neck Surgery
Apr 9, 2026 - 13:18
Radio and PodcastLive Radio & Podcasts
Health
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related...
About This Episode
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab is an episode from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the...
Podcast
This episode belongs to JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jul 31, 2025, 17:45 long, audio available.
Related Episodes
Continue listening to more episodes from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck.
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma
Mar 26, 2026 - 11:33
Why Hearing Health Must Be Part of Voice Biomarker Research
Jan 2, 2026 - 14:20
Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction
Dec 11, 2025 - 16:11
Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation
Nov 13, 2025 - 19:07
The JAMA Otolaryngology-Head & Neck Surgery Editorial Fellowship Experience
Oct 16, 2025 - 08:54
Stellate Ganglion Block for the Treatment of COVID-19−Induced Parosmia
Aug 14, 2025 - 19:42
Questions About This Episode
What is Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab about?
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab Emerging Role of Pathologic Response in Head and Neck Squamous Cell Carcinoma Immunotherapy
Where can I listen to Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab?
You can listen to Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab from?
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab is an episode from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck by American Medical Association.
How long is this episode?
This episode is 17:45 long.
When was this episode published?
This episode was published on Jul 31, 2025.
Can I save Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck?
Yes. This page shows related episodes from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab?
You can listen to Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab is from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck by American Medical Association.
What are the episode details?
Published Jul 31, 2025 and 17:45 long